☰ 目次
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia
ACC/AHA/HRS・2015・69 ページ · 不整脈・デバイス・アブレーション · 集中治療・救急・蘇生
目次 閉じる
2015 ACC/AHA/HRS Guideline for the Management of1 Adult Patients With Supraventricular Tachycardia1 the Heart Rhythm Society1 Evidence Review Committee Chair‡1 ACC/AHA/HRS Guideline1 3-Dimensional Electroanatomic Mapping . . . e518 2.5.3. Mapping and Ablation With No2 1 Introduction3 1.1 Methodology and Evidence Review3 1.2 Organization of the GWC5 1.3 Document Review and Approval5 1.4 Scope of the Guideline5 2 General Principles5 2.1 Mechanisms and Definitions5 2.2 Epidemiology, Demographics, and Public5 2.3 Evaluation of the Patient With Suspected6 or Documented SVT6 2.4 Principles of Medical Therapy10 2.5 Basic Principles of Electrophysiological Study, Mapping, and Ablation13 3 Sinus Tachyarrhythmias15 3.1 Physiological Sinus Tachycardia16 3.2 Inappropriate Sinus Tachycardia16 4 Nonsinus Focal Atrial Tachycardia and MAT18 4.1 Focal Atrial Tachycardia18 4.2 Multifocal Atrial Tachycardia22 5 Atrioventricular Nodal Reentrant Tachycardia26 5.1 Acute Treatment: Recommendations27 5.2 Ongoing Management: Recommendations28 6 Manifest and Concealed29 6.1 Management of Patients With Symptomatic30 6.2 Management of Asymptomatic Pre-Excitation32 1 What is the comparative predictive accuracy of inva-32 7 Atrial Flutter34 7.1 Cavotricuspid Isthmus–Dependent Atrial Flutter34 7.2 Non–Isthmus-Dependent Atrial Flutters35 7.3 Acute Treatment: Recommendations36 7.4 Ongoing Management: Recommendations37 8 Junctional Tachycardia39 8.1 Acute Treatment: Recommendations39 8.2 Ongoing Management: Recommendations40 9 Special Populations40 9.1 Pediatrics40 9.2 Patients With Adult Congenital Heart Disease44 9.3 Pregnancy48 9.4 SVT in Older Populations50 10 Quality-of-Life Considerations50 11 Cost-Effectiveness50 12 Shared Decision Making51 13 Evidence Gaps and Future Research Needs51 Presidents and Staff52 Education, and Quality52 Advisor Alexa Papaila, Project Manager, Science and Clinical Policy52 Office of Science Operations52 References 1. Committee on Standards for Developing Trustworthy Clinical Practice52 42 DiMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supra-54 64 Auricchio A, Klein H, Trappe HJ, et al. Lack of prognostic value of54 89 Madsen CD, Pointer JE, Lynch TG. A comparison of adenosine and vera-55 9.4 Andrea M. Russo65
p.1
p.2
p.3
p.4
p.5
p.6
p.7
p.8
p.9
p.10
p.11
p.12
p.13
p.14
p.15
p.16
p.17
p.18
p.19
p.20
p.21
p.22
p.23
p.24
p.25
p.26
p.27
p.28
p.29
p.30
p.31
p.32
p.33
p.34
p.35
p.36
p.37
p.38
p.39
p.40
p.41
p.42
p.43
p.44
p.45
p.46
p.47
p.48
p.49
p.50
p.51
p.52
p.53
p.54
p.55
p.56
p.57
p.58
p.59
p.60
p.61
p.62
p.63
p.64
p.65
p.66
p.67
p.68
p.69
🔍 検索
💬 AI
📚 閲覧
☰ 一覧
🔔 更新2